In patients with dementia, the use of risperidone is associated with an increased risk for stroke, regardless of a previous ...

A major U.K. study of more than 165,000 dementia patients has found that risperidone raises stroke risk without exception, ...

Introduction Mitochondrial dysfunction and disrupted cerebral energy metabolism have been increasingly linked to the pathophysiology of schizophrenia. Preclinical studies suggest that certain atypical ...

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...

FDA approves UZEDY ® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to ...